Revenio Group Corporation Stock Exchange Release February 26, 2015 at 09:00 REVENIO GROUP CORPORATION PUBLISHES ANNUAL REPORT 2014 Today, Revenio Group Corporation published the annual report for 2014. The AR, available in Finnish in PDF format on the corporations' website at www.reveniogroup.fi, contains financial statements for the corporation and parent company, the report of the Board of Directors, auditors report and a report on corporate governance. The AR will be published in print in week 12. To order a copy, place an order with Revenio Group Corporation, Äyritie 22, FI-01510 Vantaa, tel. +358 50 382 0131 (on weekdays between 9.00-16.00) or by e-mail elina.kari@revenio.fi. Revenio Group Corporation Olli-Pekka Salovaara President and CEO For further information, please contact: Olli-Pekka Salovaara, President and CEO, mobile +358 40 567 5520 olli-pekka.salovaara@revenio.fi http://www.revenio.fi DISTRIBUTION: Nasdaq Helsinki Financial Supervisory Authority (FIN-FSA) Key media www.revenio.fi The Revenio Group in brief Revenio is a Finnish health tech group whose core business lies in tonometers. The Revenio Health Tech segment comprises the business operations of Icare Finland Oy and Oscare Medical Oy, which specializes in osteoporosis screening and assessment. In addition, Revenio has identified new growth opportunities relating to health tech in which common denominators are screening, follow-up and the global need to make cost savings in health care through preventive measures. Revenio seeks vigorous growth in health technology, both organically and through acquisitions and mergers. In 2014, the Revenio Group's net sales totaled MEUR 16.0, with its operating margin for continuing operations standing at 27,5%. The Revenio Group Corporation is listed on Nasdaq Helsinki. [HUG#1897160]
Revenio Group Corporation: Revenio Group Corporation publishes Annual Report 2014
| Source: Revenio Group Oyj